Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice.
Saved in:
| Title: | Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice. |
|---|---|
| Authors: | Weckmann K; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Deery MJ; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Howard JA; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Feret R; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Dethloff F; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Filiou MD; Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece., Labermaier C; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Maccarrone G; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Lilley KS; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Mueller M; Experimental Psychiatry, Department of Psychiatry and Psychotherapy and Focus Program Translational Neuroscience, Johannes Gutenberg University Medical Center, Mainz, Germany., Turck CW; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany. |
| Source: | Molecular neuropsychiatry [Mol Neuropsychiatry] 2019 Mar; Vol. 5 (1), pp. 42-51. Date of Electronic Publication: 2018 Nov 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101649121 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2296-9209 (Print) Linking ISSN: 22969179 NLM ISO Abbreviation: Mol Neuropsychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31019917 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Weckmann+K%22">Weckmann K</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Deery+MJ%22">Deery MJ</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Howard+JA%22">Howard JA</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Feret+R%22">Feret R</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Asara+JM%22">Asara JM</searchLink>; Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dethloff+F%22">Dethloff F</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Filiou+MD%22">Filiou MD</searchLink>; Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece.<br /><searchLink fieldCode="AU" term="%22Labermaier+C%22">Labermaier C</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Maccarrone+G%22">Maccarrone G</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Lilley+KS%22">Lilley KS</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mueller+M%22">Mueller M</searchLink>; Experimental Psychiatry, Department of Psychiatry and Psychotherapy and Focus Program Translational Neuroscience, Johannes Gutenberg University Medical Center, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Turck+CW%22">Turck CW</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101649121%22">Molecular neuropsychiatry</searchLink> [Mol Neuropsychiatry] 2019 Mar; Vol. 5 (1), pp. 42-51. <i>Date of Electronic Publication: </i>2018 Nov 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101649121 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2296-9209 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222969179%22">22969179 </searchLink><i>NLM ISO Abbreviation: </i>Mol Neuropsychiatry <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31019917 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1159/000493425 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 42 Titles: – TitleFull: Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weckmann K – PersonEntity: Name: NameFull: Deery MJ – PersonEntity: Name: NameFull: Howard JA – PersonEntity: Name: NameFull: Feret R – PersonEntity: Name: NameFull: Asara JM – PersonEntity: Name: NameFull: Dethloff F – PersonEntity: Name: NameFull: Filiou MD – PersonEntity: Name: NameFull: Labermaier C – PersonEntity: Name: NameFull: Maccarrone G – PersonEntity: Name: NameFull: Lilley KS – PersonEntity: Name: NameFull: Mueller M – PersonEntity: Name: NameFull: Turck CW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2019 Mar Type: published Y: 2019 Identifiers: – Type: issn-print Value: 2296-9209 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: Molecular neuropsychiatry Type: main |
| ResultId | 1 |